Consumer Reports yanks its "Recommended" rating from the 3-row GMC Acadia due to owner-reported failures, citing poor ...
Acadia Realty Trust (AKR) is back in the spotlight after a string of conflicting analyst calls, with fresh downgrades clashing against renewed buy ratings and leaving investors reassessing the REIT’s ...
Pharmaceutical Technology on MSN
FDA approves Acadia’s Daybue Stix for Rett syndrome
The US Food and Drug Administration has approved Acadia Pharmaceuticals’ Daybue Stix (trofinetide), a dye and ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catherine Owen Adams, Chief Executive Officer ...
Acadia Pharmaceuticals Inc. is rated a Buy for its steady NUPLAZID/DAYBUE franchises & pipeline-driven upside potential. Read ...
Fintel reports that on December 18, 2025, Mizuho maintained coverage of Acadia Healthcare (NasdaqGS:ACHC) with a Neutral ...
Although renowned for dozens of spectacular peaks, Acadia National Park on Mount Desert Island has more than outstanding ...
Acadia Healthcare faces rising legal, insurance, and compliance costs and a Medicaid-heavy payer mix under policy pressure.
17d
Bar Harbor businesses fear economic hit as Acadia National Park adds $100 fee for non-US tourists
A new $100 surcharge for non-U.S. visitors to Acadia and other national parks raises alarm among Bar Harbor businesses. BAR HARBOR, Maine — Starting next year, non-U.S. residents will need to pay an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback